Published large human clinical-trial data is not available, so consumer time to results framings sit outside the public regulatory evidence base
Frequently asked questions about Wegovy Answered by our experienced medical team
Common adverse effects reported in clinical trials include: Paraesthesia (tingling sensations in extremities) occurring in 2025% of participants, attributed to topiramate's carbonic anhydrase inhibition [4] [5] Dry mouth affecting approximately 20% of users, related to phentermine's sympathomimetic effects Constipation reported in 1517% of participants Dysgeusia (altered taste perception) particularly metallic taste, affecting 1015% Insomnia occurring in 1012%, linked to phentermine's stimulant properties Dizziness and cognitive effects including difficulty with concentration, memory, and word-finding Serious safety concerns require particular attention
Predictive factors of response to liraglutide in patients with type 2 diabetes mellitus and metabolic syndrome
Other health considerations (kidney, liver, gallbladder, cardiovascular health)
Yes, you can permanently change